LUGPA 2025 Global Prostate Cancer Congress Enduring Program-GPCC 2025 Session 1

Video Transcription
Video Summary
This video features a comprehensive discussion focused on men's health, particularly concerning prostate cancer, cardiometabolic risks, caregiving challenges, bone health, and supportive care programs.<br /><br />Dr. Marty Miner opens with insights on men's health disparities, highlighting that men have a shorter life expectancy due to factors like poor cardiometabolic health, obesity, diabetes, and hypertension. He underscores the rising obesity epidemic and the importance of preventive care, including managing blood pressure, glucose, and lipids. He discusses advances in obesity treatment with GLP-1 receptor agonists like semaglutide, which improve cardiovascular outcomes but may lead to loss of lean body mass, mitigated by resistance training and protein intake. He also advocates liberalizing PDE5 inhibitors (e.g., daily tadalafil) due to evidence suggesting they reduce male mortality and cardiovascular risk.<br /><br />Dr. David Boris addresses cardiovascular risks associated with androgen deprivation therapy (ADT) used in prostate cancer treatment. He notes the FDA’s black box warning due to increased cardiovascular event risks and discusses the ongoing debate on agonist versus antagonist therapies and the heightened risks when combining ADT with androgen receptor inhibitors. He emphasizes lifestyle interventions—exercise and diet (low carb or Mediterranean)—to mitigate these risks and stresses the importance of coordinated care involving primary providers.<br /><br />Rena Cherry highlights the burden on informal caregivers—mostly women—who provide unpaid, extensive support for prostate cancer patients. Caregivers face financial strain, communication challenges with multiple providers, and emotional struggles such as guilt and shame. She calls for acknowledging caregivers in clinical settings, providing support resources, respite care, and fostering community to alleviate caregiver isolation.<br /><br />Scott Selinger introduces the congress logistics and emphasizes industry support.<br /><br />Other speakers focus on bone health in prostate cancer patients on ADT, discussing bone density loss, fracture risks, monitoring via DEXA scans, and treatments including bisphosphonates (e.g., zoledronic acid) and denosumab. They caution about side effects like osteonecrosis of the jaw and recommend lifestyle measures like weight-bearing exercises and vitamin D supplementation.<br /><br />Tim, a prostate cancer patient, shares his personal journey, emphasizing the role of advanced imaging (PSMA scans), treatment decisions, and the importance of exercise and mental resilience.<br /><br />Dr. Tia Higano presents a successful supportive care program from the Vancouver Prostate Center that offers modular, virtual, and multidisciplinary care for men with prostate cancer, highlighting its accessibility and patient satisfaction.<br /><br />The session concludes with a panel discussion touching on caregiver support, metabolic differences influencing obesity, the cardiovascular benefits of PDE5 inhibitors, and the trade-offs in prostate cancer therapies regarding efficacy and cardiovascular risks.<br /><br />Overall, the program stresses integrated approaches addressing physical health, mental well-being, caregiver support, and innovative treatment paradigms to optimize outcomes for men with prostate cancer.
Keywords
men's health
prostate cancer
cardiometabolic risks
obesity epidemic
GLP-1 receptor agonists
PDE5 inhibitors
androgen deprivation therapy
cardiovascular risks
caregiver support
bone health
supportive care programs
advanced imaging